These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10855464)

  • 1. Association of paroxetine with suicide attempt in obsessive-compulsive disorder.
    Göder R; Friege L; Treskov V; Grohmann R; Aldenhoff JB
    Pharmacopsychiatry; 2000 May; 33(3):116-7. PubMed ID: 10855464
    [No Abstract]   [Full Text] [Related]  

  • 2. SSRI-induced mania in obsessive-compulsive disorder.
    Diler RS; Avci A
    J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):6-7. PubMed ID: 9893408
    [No Abstract]   [Full Text] [Related]  

  • 3. Obsessive-compulsive spectrum disorders: effective treatment with paroxetine.
    Ravindran AV; Lapierre YD; Anisman H
    Can J Psychiatry; 1999 Oct; 44(8):805-7. PubMed ID: 10566112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia].
    Scholl HP; Kasper S; Danos P; Höflich G; Möller HJ
    Nervenarzt; 1994 Jul; 65(7):478-81. PubMed ID: 7800092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paroxetine and tardive akathisia.
    Boffa E; Lofchy J
    Can J Psychiatry; 2000 Mar; 45(2):196. PubMed ID: 10742880
    [No Abstract]   [Full Text] [Related]  

  • 6. Topiramate augmentation in a patient with obsessive-compulsive disorder.
    Van Ameringen M; Patterson B
    J Psychiatry Neurosci; 2015 Sep; 40(5):E31-2. PubMed ID: 26290064
    [No Abstract]   [Full Text] [Related]  

  • 7. Antidepressant medications in children.
    Vitiello B; Swedo S
    N Engl J Med; 2004 Apr; 350(15):1489-91. PubMed ID: 15071123
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
    Ammar G; Naja WJ; Pelissolo A
    Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.
    Denys D; van der Wee N; van Megen HJ; Westenberg HG
    J Clin Psychopharmacol; 2003 Dec; 23(6):568-75. PubMed ID: 14624187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine.
    Hollander E; Allen A; Steiner M; Wheadon DE; Oakes R; Burnham DB;
    J Clin Psychiatry; 2003 Sep; 64(9):1113-21. PubMed ID: 14628989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features.
    Strous RD; Patel JK; Zimmet S; Green AI
    Am J Psychiatry; 1999 Jun; 156(6):973-4. PubMed ID: 10360153
    [No Abstract]   [Full Text] [Related]  

  • 12. Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients.
    Kamijima K; Murasaki M; Asai M; Higuchi T; Nakajima T; Taga C; Matsunaga H
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):427-33. PubMed ID: 15298657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of social phobia with obsessive-compulsive symptoms improved by paroxetine in combination with risperidone.
    Yamauchi K; Ohta K; Taniguchi T; Ohmori T
    Gen Hosp Psychiatry; 2004; 26(3):242-3. PubMed ID: 15121355
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined pharmacotherapy risk.
    Budman CL; Sherling M; Bruun RD
    J Am Acad Child Adolesc Psychiatry; 1995 Mar; 34(3):263-4. PubMed ID: 7896663
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care.
    Denys D; van Megen HJ; Westenberg HG
    J Psychopharmacol; 2003 Mar; 17(1):127-9. PubMed ID: 12680750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.
    Mundo E; Bianchi L; Bellodi L
    J Clin Psychopharmacol; 1997 Aug; 17(4):267-71. PubMed ID: 9241005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine Treatment of Problematic Pornography Use: A Case Series.
    Gola M; Potenza MN
    J Behav Addict; 2016 Sep; 5(3):529-32. PubMed ID: 27440474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
    Zohar J; Judge R
    Br J Psychiatry; 1996 Oct; 169(4):468-74. PubMed ID: 8894198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine.
    Brody AL; Saxena S; Fairbanks LA; Alborzian S; Demaree HA; Maidment KM; Baxter LR
    J Clin Psychiatry; 2000 May; 61(5):349-55. PubMed ID: 10847309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.